AHWISPO — 2431734
Application number
2431734
Type(s)
Standard Characters
Category
Trademark
CIPO Status
SEARCHED
TM5 status
LIVE/APPLICATION/
Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.
Filed
2025-10-20
Applicant
Bristol-Myers Squibb Company
Route 206 & Province Line Road
Princeton, NJ 08543
UNITED STATES OF AMERICA
Agent
GOWLING WLG (CANADA) LLP
SUITE 1600
1 FIRST CANADIAN PLACE
100 KING STREET WEST
TORONTO
ONTARIO M5X1G5
Documents
Index headings
- AHWISPO
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes.
Claims
- Priority Filing Date: June 27, 2025, Country or Office: UNITED STATES OF AMERICA, Application No. 99256173 in association with the same kind of goods
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2025-10-20 | ||
| Created | 2025-10-20 | ||
| Formalized | 2025-10-20 | ||
| Pre-Assessment Letter Sent | 2025-10-30 | Retired Goods or Services | |
| Search Recorded | 2026-06-17 | ||
| Examiner's First Report | 2026-06-17 | 2026-12-17 |